A Study of the Safety and Efficacy of Ustekinumab in Patients with Psoriatic Arthritis with and without Prior Exposure to Anti-TNF Agents

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-012265-60

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objectives of this study are to evaluate the efficacy of ustekinumab in subjects with active PsA including those previously treated with biologic anti-TNFα agent(s) by assessing the reduction in signs and symptoms of PsA and to evaluate the safety of ustekinumab in this population.


Critère d'inclusion

  • Psoriatic Arthritis